PortalPublikationenDocetaxel combined with irinotecan or 5-fluorouracil in pati...

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.

Links

  • A Roy
  • D Cunningham
  • R Hawkins
  • H Sörbye
  • A Adenis
  • J-R Barcelo
  • G Lopez-Vivanco
  • G Adler
  • J-L Canon
  • F Lofts
  • C Castanon
  • E Fonseca
  • O Rixe
  • J Aparicio
  • J Cassinello
  • M Nicolson
  • M Mousseau
  • A Schalhorn
  • L D'Hondt
  • J Kerger
  • Dieter Hossfeld
  • C Garcia Giron
  • R Rodriguez
  • P Schoffski
  • J-L Misset

Beteiligte Einrichtungen

Abstract

Docetaxel and irinotecan chemotherapy have shown good efficacy in the treatment of advanced oesophago-gastric cancer. This randomised phase II study evaluated the efficacy and toxicity profile of two non-platinum docetaxel-based doublet regimens in advanced oesophago-gastric cancer.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer3
ISSN0007-0920
StatusVeröffentlicht - 2012
pubmed 22767144